Ligand profile
BVU
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_03859 — Dihydroorotate dehydrogenase
Identifiers
Database identifiers and provenance.
- Ligand ID
BVU- PDB
6jme- UniProt (similar protein)
Q02127- Target protein
- KP13_03859
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 64.8
- −1 ≤ LogP ≤ 5 4.13
- MW ≤ 500 Da 405.3
- LogP ≤ 5 4.13
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 64.8
Matches PAINS filter: quinone_A(370). May be a frequent false positive in HTS — review carefully.
Chemical representations
Canonical representations for cheminformatics workflows.
c1ccc(c(c1)c2c(cc(cc2F)n3c4c(nn3)C(=O)c5ccccc5C4=O)F)Fc1ccc(c(c1)c2c(cc(cc2F)n3c4c(nn3)C(=O)c5ccccc5C4=O)F)F
InChI=1S/C22H10F3N3O2/c23-15-8-4-3-7-14(15)18-16(24)9-11(10-17(18)25)28-20-19(26-27-28)21(29)12-5-1-2-6-13(12)22(20)30/h1-10HInChI=1S/C22H10F3N3O2/c23-15-8-4-3-7-14(15)18-16(24)9-11(10-17(18)25)28-20-19(26-27-28)21(29)12-5-1-2-6-13(12)22(20)30/h1-10H
VMUZFSZBQDZDTG-UHFFFAOYSA-NVMUZFSZBQDZDTG-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF01180
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand BVU →
- PDB RCSB structure 6jme →
- UniProt UniProt Q02127 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “BVU”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03859.
PDB 74
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).